Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PrEP Biopharm

PrEP Biopharm?uq=PEM9b6PF
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$32.4M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of drugs designed to address unmet medical needs. The company's PrEP-001 is an immunomodulator that focuses on the cure of common cold and other respiratory diseases including prophylaxis for upper respiratory tract infections, enabling patients to be cured from viral infections at an earliest possible time.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Queen Mary Bioenterprises Innovation Centre
  • 42 New road
  • London E1 2AX
  • England
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PrEP Biopharm’s full profile, request a free trial.

PrEP Biopharm Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 16-Nov-2015 $32.4M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

PrEP Biopharm Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
hVIVO Corporation Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0

PrEP Biopharm Executive Team (3)

Name Title Board
Seat
Contact
Info
Ryan Muldoon Co-Founder, Chief Executive Officer and Board Member
Bruce Malcolm Ph.D Co-Founder & Chief Scientific Officer
Timothy Jenkins Ph.D Vice President of Clinical Development

PrEP Biopharm Board Members (5)

Name Representing Role Since Contact
Info
Clive Page Ph.D PrEP Biopharm Board Member 000 0000
Graham Edward Yeatman hVIVO Board Member 000 0000
James Cornelius PrEP Biopharm Board Member 000 0000
Kym Lynn Denny hVIVO Board Member 000 0000
Ryan Muldoon PrEP Biopharm Co-Founder, Chief Executive Officer and Board Member 000 0000